JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on September 3, 2003; DOI: 10.1124/jpet.103.051995


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.051995v1
307/1/223    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quilley, J.
Right arrow Articles by Hirt, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quilley, J.
Right arrow Articles by Hirt, J.


Received for publication March 25, 2003.
Revised April 17, 2003.
Accepted for publication June 26, 2003.

Inhibitors of 20-HETE reduce renal vasoconstrictor responsiveness

John Quilley 1*, Yue Qiu 2, Joseph Hirt 1

1 New York Medical College 2 UMDNJ-SOM

* Address correspondence to: E-mail: john_quilley{at}nymc.edu

Abstract

20-HETE is a CYP-derived constrictor eicosanoid produced by the preglomerular vasculature where it contributes to regulation of tone. Removal of the tonic inhibitory influence of NO has been reported to increase renal 20- HETE release. As inhibition of NO synthesis enhances responses to vasoconstrictor agents, we examined a contribution for increased 20-HETE generation. In the rat kidney perfused with Krebs' buffer, responses to U46619, a TxA2 mimetic, were compared before and after 50µM L-nitroarginine (L-NA) to inhibit NOS. L-NA raised perfusion pressure (PP) from 79±3 mmHg to 190±7 mmHg and enhanced constrictor responsiveness to U46619. 10, 30, 100 and 300 ng U46619 increased PP by 7±1, 17±2, 50±7 and 67±7 mmHg, respectively, before L-NA and 15 ±1, 37±7, 68±10 and 85±11 mmHg, respectively, after L-NA which did not increase 20- HETE efflux from the kidney. Nonetheless, an inhibitor of {omega}-hydroxylase, DDMS which reduced 20-HETE release, normalized the enhanced responsiveness to U46619. When PP was elevated with phenylephrine, vasoconstrictor responses to U46619 were similarly enhanced, an effect that was also prevented by DDMS. DDMS and an antagonist of 20-HETE, 20-HEDE, also reduced vasoconstrictor responses to U46619 in the absence of elevation of PP. As 20-HETE inhibits K+ channels, we examined the effects of K+ channel inhibitors on vasoconstrictor responses and showed that both TEA and charybdotoxin enhanced renal vasoconstrictor responses to U46619. However, the inhibitory effects of 20-HEDE on vasoconstrictor responses remained after treatment with TEA. These results support a role for 20-HETE vasoconstrictor responses but suggest an action independent of K+ channels.


Key words: 20-HETE, DDMS, K channel inhibitors, kidney, nitric oxide, vasoconstriction


This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
A. D. Baines and P. Ho
20-HETE-mediated vasoconstriction by hemoglobin-O2 carrier in Sprague-Dawley but not Wistar rats
J Appl Physiol, March 1, 2005; 98(3): 772 - 779.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. M. Hamza and S. Kaufman
A vibrator prevents streaming during close-arterial infusion into the kidney
Am J Physiol Renal Physiol, April 1, 2004; 286(4): F643 - F646.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.